Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.
NCT ID: NCT02366299
Last Updated: 2019-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2015-02-28
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Various Sedation Regimens on the Incidence of Delirium
NCT02117726
Dexmedetomidine and Delirium in Patients After Cardiac Surgery
NCT02267538
Sedation of Mechanically Ventilated Critically Ill Patients: Midazolam Versus Dexmedetomidine
NCT01256866
Comparison Between the Effect of Dexmedetomidine _midazolam and ketamine_midazolam Combination
NCT07074262
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium
NCT00351299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexmedetomidine
Treatment of delirium by dexmedetomidine i.v. infusion
Dexmedetomidine
Treatment of delirium by dexmedetomidine i.v. infusion
propofol
Treatment of delirium by propofol i.v. infusion
Propofol
Treatment of delirium by Propofol i.v. infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
Treatment of delirium by dexmedetomidine i.v. infusion
Propofol
Treatment of delirium by Propofol i.v. infusion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* any mental disorder
* presence of cancer
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moscow Regional Research and Clinical Institute (MONIKI)
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valery V. Likhvantsev, Professor
senior researcher
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D-P-SIRS-220115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.